mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.2 |